DSP Healthcare Fund Direct Growth

DSP Healthcare Fund Direct Growth

Equity

DSP Mutual Fund

Sector - Healthcare

Get the latest NAV of DSP Healthcare Fund Direct Growth. View historical returns compared to its benchmark and category average. Know which stocks and sectors the fund is investing in. Get an estimate of returns from the SIP and lump sum returns calculator. View detailed holding analysis and peer comparison. Get INDmoney ranking of the fund.

₹42.41

▲0.5%1D

NAV as on 26 Jun 2025

24.59%/per year

Since Inception

Absolute Gain%

▲▼

8106 people have invested ₹ 2.1Cr in DSP Healthcare Fund Direct Growth in the last three months

DSP Healthcare Fund Performance vs. Nifty 500

Fund returns vs Benchmark returns vs Category Average returns as on (26-Jun-25)

The fund has consistently outperformed the benchmark (Nifty 500) over the last 1Y, 3Y, 5Y time periods.

Period
This Fund
Nifty 500
Category Avg
1 Month
2.92%
3.52%
1.81%
3 Months
3.34%
10.33%
4.85%
6 Months
-6.06%
5.23%
-1.96%
1 Year
18.13%
4.8%
17.37%
3 Years
27.49%
20.66%
24.65%
5 Years
24.56%
22.51%
21.45%

INDmoney Rank

Powered by IND quant engine

IND ranking is not available for this fund.

Fund Name
INDmoney Rank
AUM (in Crs.)
Expense Ratio
1Y Returns
3Y Returns
Inception Returns
DSP Healthcare Fund
4/8
2,961Cr
0.62%
18.13%
27.49%
24.59%
SBI Healthcare Opportunities Fund Direct Growth
1/8
3,689Cr
0.9%
21.24%
30.02%
18.23%
ICICI Prudential Pharma Healthcare and Diagnostics P.H.D Fund Direct Growth
2/8
5,508Cr
1.06%
23.01%
30.63%
22.92%
Tata India Pharma & Healthcare Fund Direct Growth
3/8
1,232Cr
0.63%
15.92%
26.37%
13.96%
See all
Positive: 5Y returns in the top 25% of the category
5Y returns in the top 25% of the category
Positive: Among most bought funds within the category
Among most bought funds within the category
Positive: Beats FD returns for both 3Y & 5Y duration
Beats FD returns for both 3Y & 5Y duration
Negative: No bad points found for this fund.
No bad points found for this fund.

DSP Healthcare Fund Returns Calculator

Calculate SIP and lumpsum returns based on historical performance

  • 1-time

  • SIP

Total Investment

0

Profit

Total Corpus

0

Absolute Return
▲
▼

DSP Healthcare Fund Asset Allocation

See fund asset allocation details as on (14-Jun-25)

Fund Distribution

as on (14-Jun-25)

Equity 99.6%

Debt & Cash 0.4%

Small cap
53.5%
Large cap
17.6%
Mid cap
14.9%
Large Cap allocation has gone down from 19.2% to 17.6%
Large Cap allocation has gone down from 19.2% to 17.6%
Small Cap allocation has gone up from 51.3% to 53.5%
Small Cap allocation has gone up from 51.3% to 53.5%
Mid Cap allocation has gone down from 15% to 14.9%
Mid Cap allocation has gone down from 15% to 14.9%
Cash allocation has gone up from 0.1% to 0.4%
Cash allocation has gone up from 0.1% to 0.4%

DSP Healthcare Fund Sector Allocation

See fund sector allocation details as on (14-Jun-25)

Sector Allocation

Equity 99.6%

Debt & Cash 0.4%

Health
98.5%
Financial Services
1.5%

Top 2 Sectors in May were Health, Financial Services

May'25

Health

98%

Financial Services

2%

Apr'25

Health

98%

Financial Services

2%

DSP Healthcare Fund Holdings Details

as on (31-May-25)

Equity

Top Stocks bought last month
Pfizer Ltd's allocation increased from 2.96% to 3.8%
Pfizer Ltd's allocation increased from 2.96% to 3.8%
Alembic Pharmaceuticals Ltd's allocation increased from 4.29% to 4.91%
Alembic Pharmaceuticals Ltd's allocation increased from 4.29% to 4.91%
Gland Pharma Ltd's allocation increased from 4.43% to 4.94%
Gland Pharma Ltd's allocation increased from 4.43% to 4.94%
Top Stocks sold last month
Cipla Ltd's allocation decreased from 9.53 % to 8.86 %
Cipla Ltd's allocation decreased from 9.53 % to 8.86 %
Cohance Lifesciences Ltd's allocation decreased from 9.72 % to 8.81 %
Cohance Lifesciences Ltd's allocation decreased from 9.72 % to 8.81 %
Sun Pharmaceuticals Industries Ltd's allocation decreased from 9.66 % to 8.7 %
Sun Pharmaceuticals Industries Ltd's allocation decreased from 9.66 % to 8.7 %

DSP Healthcare Fund Direct Growth Overview

Get key fund statistics, minimum investment details, AUM, expense ratio, exit load, and tax treatment.

Expense ratio0.62%
Benchmark
BSE Healthcare TR INR
AUM₹2961 Cr
Inception Date30 November, 2018
Min Lumpsum/SIP₹100/₹100
Exit Load
0.5%
Lock InNo Lock-in
TurnOver
2.15%
STCGSelling mutual fund before 1 year, returns taxed at 20%.
LTCGAfter 1 year, 12.5% tax on returns over ₹1.25 lakh/year.
Risk
Risk meter
pointer
Very High Risk

About DSP Healthcare Fund

DSP Healthcare Fund Direct Growth is an equity fund. This fund was started on 30 November, 2018. The fund is managed by Chirag Dagli. The fund could potentially beat inflation in the long-run.

Key Parameters

  1. DSP Healthcare Fund Direct Growth has ₹2961 Cr worth of assets under management (AUM) as on Jun 2025 and is more than category average.
  2. The fund has an expense ratio 0.6.

Returns

DSP Healthcare Fund Direct Growth has given a CAGR return of 24.59% since inception. Over the last 1, 3 and 5 years the fund has given a CAGR return of 18.13%, 27.49% and 24.56% respectively.

Holdings

DSP Healthcare Fund Direct Growth has allocated its funds majorly in Cash Equivalent, Health, Financial Services. Its top holdings are Cipla Ltd, Cohance Lifesciences Ltd, Sun Pharmaceuticals Industries Ltd, Ipca Laboratories Ltd, Gland Pharma Ltd

Taxation

As it is a sector - healthcare mutual fund the taxation is as follows:
For short term (less than a year) capital gains will be taxed at 20%
For long term (more than 1 year) capital gains will be taxed at 12.5% without indexation benefit
Dividends will always be taxed at slab rate. Long term gains upto Rs 1 lakh are exempt capital gains tax.

Investment objective of DSP Healthcare Fund Direct Growth

The primary investment objective of the scheme is to seek to generate consistent returns by predominantly investing in equity and equity related securities of pharmaceutical and healthcare companies. However, there can be no assurance that the investment objective of the scheme will be realized.

Minimum Investment and lockin period

Minimum investment for lump sum payment is INR 100.00 and for SIP is INR 100.00. DSP Healthcare Fund Direct Growth has no lock in period.

Fund Manager

Chirag Dagli

Fund Manager of DSP Healthcare Fund Direct Growth, since 1 December 2020

Learn more about DSP Mutual Fund
Parameters
May'25
Apr'25
Mar'25
AUM
₹ 3K Cr
₹ 2.9K Cr
₹ 3K Cr
  • AUM of the fund stands at 3K Cr as of May'25
  • AUM increased by 49.4 Cr between May'25 and Apr'25

Compare DSP Healthcare Fund

DSP Healthcare Fund

VS

Nippon India Pharma Fund Direct Growth

Frequently Asked Questions for DSP Healthcare Fund Direct Growth

How do I invest in DSP Healthcare Fund?

INDmoney makes it simple to invest in the DSP Healthcare Fund. To do so, follow the steps below:
  • Download the INDmoney app.
  • Search for ‘DSP Healthcare Fund’.
  • Select whether you want to invest in SIP or lump sum.
  • Enter the amount you wish to invest.
  • Set up payments via bank mandate or UPI.

What is the current NAV of DSP Healthcare Fund?

The NAV of the fund today is ₹42.41. NAV or Net Asset Value is the per unit price of a mutual fund. For example, if the NAV of a fund is ₹10, it means you can get 1000 units of that mutual fund at ₹10,000.

What is the return on the fund?

DSP Healthcare Fund fund has generated a return of 18.13% in 1 year, 27.49% in 3 years, 24.56% in 5 years.

Who is the fund manager of DSP Healthcare Fund?

The fund managers are Chirag Dagli.

What is the exit load of the fund?

The exit load is 0.5% if redeemed in 0-1 Months. Exit load is a fee levied for ‘exiting’ the fund earlier than a stipulated period, usually 1 year.

What is the expense ratio of the fund?

The expense ratio is 0.62%. The Expense Ratio is a fee charged for managing the fund. This includes commissions, administrative costs etc.

What is the AUM of the fund?

The AUM of the fund is ₹2961 Cr. AUM stands for Assets Under Management. It refers to the total assets managed by the fund.

What are the top holdings of DSP Healthcare Fund?

The top 3 holdings of the fund are Cipla Ltd(8.86%), Cohance Lifesciences Ltd(8.81%), Sun Pharmaceuticals Industries Ltd(8.7%)